What have we learned from the calcium channel blocker controversy?

[1] [Anonymous], 1986, LANCET, V2, P57

[2] BILLMAN GE, 1991, J CARDIOVASC PHARM, V18, pS107

[3] PHYSICIANS BEHAVIOR AND THEIR INTERACTIONS WITH DRUG COMPANIES - A CONTROLLED-STUDY OF PHYSICIANS WHO REQUESTED ADDITIONS TO A HOSPITAL DRUG FORMULARY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09): : 684 - 689

[4] Valvular heart disease associated with fenfluramine-phentermine [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) : 581 - 588

[5] PUBLICATION BIAS - THE PROBLEM THAT WONT GO AWAY [J]. DOING MORE GOOD THAN HARM: THE EVALUATION OF HEALTH CARE INTERVENTIONS, 1993, 703 : 135 - 148

[6] ROLE OF CORONARY VASOSPASM IN THE PATHOGENESIS OF MYOCARDIAL-INFARCTION - STUDY IN PATIENTS WITH NO SIGNIFICANT CORONARY STENOSIS [J]. AMERICAN HEART JOURNAL, 1993, 126 (06) : 1305 - 1311

[7] NIFEDIPINE - DOSE-RELATED INCREASE IN MORTALITY IN PATIENTS WITH CORONARY HEART-DISEASE [J]. CIRCULATION, 1995, 92 (05) : 1326 - 1331

[8] CALCIUM-CHANNEL BLOCKERS IN ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA - AN OVERVIEW [J]. BMJ-BRITISH MEDICAL JOURNAL, 1989, 299 (6709): : 1187 - 1192

[9] SPINNING THE RISKS AND BENEFITS OF CALCIUM-ANTAGONISTS [J]. LANCET, 1995, 346 (8975): : 586 - 587

[10] CALCIUM-ANTAGONISTS IN HYPERTENSION [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 86 (4A) : 6 - 14

[1] [Anonymous], 1986, LANCET, V2, P57

[2] BILLMAN GE, 1991, J CARDIOVASC PHARM, V18, pS107

[3] PHYSICIANS BEHAVIOR AND THEIR INTERACTIONS WITH DRUG COMPANIES - A CONTROLLED-STUDY OF PHYSICIANS WHO REQUESTED ADDITIONS TO A HOSPITAL DRUG FORMULARY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09): : 684 - 689

[4] Valvular heart disease associated with fenfluramine-phentermine [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) : 581 - 588

[5] PUBLICATION BIAS - THE PROBLEM THAT WONT GO AWAY [J]. DOING MORE GOOD THAN HARM: THE EVALUATION OF HEALTH CARE INTERVENTIONS, 1993, 703 : 135 - 148

[6] ROLE OF CORONARY VASOSPASM IN THE PATHOGENESIS OF MYOCARDIAL-INFARCTION - STUDY IN PATIENTS WITH NO SIGNIFICANT CORONARY STENOSIS [J]. AMERICAN HEART JOURNAL, 1993, 126 (06) : 1305 - 1311

[7] NIFEDIPINE - DOSE-RELATED INCREASE IN MORTALITY IN PATIENTS WITH CORONARY HEART-DISEASE [J]. CIRCULATION, 1995, 92 (05) : 1326 - 1331

[8] CALCIUM-CHANNEL BLOCKERS IN ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA - AN OVERVIEW [J]. BMJ-BRITISH MEDICAL JOURNAL, 1989, 299 (6709): : 1187 - 1192

[9] SPINNING THE RISKS AND BENEFITS OF CALCIUM-ANTAGONISTS [J]. LANCET, 1995, 346 (8975): : 586 - 587

[10] CALCIUM-ANTAGONISTS IN HYPERTENSION [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 86 (4A) : 6 - 14